Skip to content
ApprovedFDA approvedStrong evidence

Galantamine

Amaryllis-alkaloid Alzheimer's drug: reversible cholinesterase inhibitor with a dual cholinergic mechanism.

NootropicCholinergicCholinergicMemoryNeuroprotectionAcetylcholinenoo.affects.memorynoo.affects.neuroprotection
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassCholinergic · Memory · Neuroprotection
Primary targetReversible acetylcholinesterase inhibitor + nicotinic allosteric potentiating ligand
Targets3 receptor targets
Half-lifeApproximately 7-8 hours
OnsetPeak plasma concentration roughly 1-2 hours after oral dosing; for lucid dreaming it is typically taken mid-sleep after several hours of rest
EvidenceStrong evidence
Affected systemsAcetylcholinenoo.affects.memorynoo.affects.neuroprotection

Contents

WHAT IS GALANTAMINE?

Detailed overview

Galantamine is a tertiary alkaloid originally isolated from the bulbs of Amaryllidaceae plants (such as snowdrop and daffodil) and now an approved prescription drug for the symptomatic treatment of mild-to-moderate Alzheimer's disease. It is a dual-mechanism cholinergic agent: it reversibly inhibits the acetylcholine-degrading enzyme acetylcholinesterase, and it acts as an allosteric potentiating ligand that amplifies the response of nicotinic acetylcholine receptors to their own transmitters. Numerous randomized, placebo-controlled trials have confirmed its modest cognitive and functional benefit in Alzheimer's disease, and off-label it is well known for stimulating lucid dreaming, supported by a 2018 double-blind, placebo-controlled crossover study. It is a prescription medicine requiring medical supervision.

Mechanism

Reversible AChE inhibitor + nicotinic APL

Half-life

Approximately 7-8 hours

Legal status

Prescription drug (Alzheimer's)

Receptor profile

  • Nicotinic acetylcholine receptors (allosteric potentiation)Strong
  • Acetylcholinesterase (reversible inhibition)Moderate
  • Cognitive decline / memoryModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Nausea and vomiting, especially early during dose titration (the most common complaint)
  • Reduced appetite and weight loss
  • Dizziness, headache, fatigue
  • Diarrhea or abdominal cramps from increased cholinergic gastrointestinal activity
  • Bradycardia (slow heart rate), fainting and rarely heart block from increased vagal tone
  • Vivid dreams or disrupted sleep if dosed close to bedtime

Contraindications · 6

  • Severe hepatic or renal impairment: dose adjustment or avoidance required
  • Bradycardia, sick sinus syndrome or other supraventricular conduction disorders: increased risk of heart block
  • Active or predisposed peptic ulcer disease due to increased gastric acid secretion
  • Asthma or severe obstructive pulmonary disease: cholinergic action may trigger bronchospasm
  • Strong CYP2D6 or CYP3A4 inhibitors (e.g. paroxetine, ketoconazole) raise exposure
  • Prescription medicine: not recommended without medical supervision and diagnosis

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Amaryllis-alkaloid Alzheimer's drug: reversible cholinesterase inhibitor with a dual cholinergic mechanism.

Telegram

Have a question about Galantamine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC17H21NO3
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.